3D Global Biotech Inc. (TPEX:6808)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Medical Equipment	144.72M
Contract Development and Manufacturing	90.07M
Technology License	30.90M
Technology License Growth	981.55%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Taiwan	134.24M
Taiwan Growth	550.62%
China	108.74M
United States	22.70M